Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • NFTs explained, how ASX-listed companies are minting NFTs in lieu of capital raises
    • Opinion

    NFTs explained, how ASX-listed companies are minting NFTs in lieu of capital raises

    If you are a Melbournian, you will remember about nine years ago when you walked through Flinders St Station and heard a song to the tune of “set fire to your hair” and “poke a stick at a grizzly bear” along with this, you would have been inundated with humanoid looking ‘bean’ characters posted everywhere

    Read More
    Public
  • Not if, but when: expansion on the horizon for Digital Wine Ventures
    • News

    Not if, but when: expansion on the horizon for Digital Wine Ventures

    I recently gave a new name to the weekly soiree my friends and I conduct. It’s called “The Wine and Whine” (I should copyright that). The W&W is a safe space, often on my couch, where we crack open a bottle of Pinot Noir and whine about anything, from the state of the world, global

    Read More
    Public
  • Aerometrex flags metaverse opportunities for 3D mapping as US business gathers momentum
    • News

    Aerometrex flags metaverse opportunities for 3D mapping as US business gathers momentum

    When inventing their technology, Aerometrex (ASX: AMX) intended to use 3D mapping to automate visualisations of architecture but fast forward to 2022 and their biggest growth opportunity may be in virtual reality with metaverse enthusiasts seeking the Company to create digital versions of major cities.  This is a prime example of how quickly technology is

    Read More
    Public
  • Blackstone locks in $8.9bn takeover offer for Crown Resorts
    • News

    Blackstone locks in $8.9bn takeover offer for Crown Resorts

    US private equity firm Blackstone Inc. has won the bidding war to acquire Crown Resorts (ASX: CWN) in a massive $8.9 billion takeover offer. Through this agreement, Blackstone will purchase all shares in Crown for a price of $12.50 per share through a Scheme of Arrangement. This offer is higher than the previous bid submitted

    Read More
    Public
  • Clinuvel to commence DNA repair drug clinical trials as new skin cancer treatment
    • News

    Clinuvel to commence DNA repair drug clinical trials as new skin cancer treatment

    Sunbaking is a certified Australian pastime, so it comes as no surprise that we have the highest melanoma rate in the world.  Any lamington-eating, Waltzing Matilda-singing Aussie knows that skin checks are an important part of preventative healthcare, and that our unfortunate position in relation to the inconvenient hole in our ozone layer means that

    Read More
    Public
  • Keypath bolsters revenue with new University pathway programs launched in SouthEast Asia
    • News

    Keypath bolsters revenue with new University pathway programs launched in SouthEast Asia

    While Australian education providers are reeling financially in the wake of the pandemic-forced mass exodus of international students, US-based education provider Keypath Education International (ASX: KED) has not had such problems, boosting revenue by 37%.  Although based out of the United States, Keypath’s increased revenue has been attributed to its international expansion where it has

    Read More
    Public
  • «
  • ‹
  • 409
  • 410
  • 411
  • 412
  • 413
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.